MDxHealth SA ROA 2018-2025 | MDXH

Current and historical return on assets (ROA) values for MDxHealth SA (MDXH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
MDxHealth SA ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $-0.04B $0.18B -25.16%
2024-12-31 $-0.04B $0.16B -27.51%
2024-09-30 $-0.04B $0.16B -31.91%
2024-06-30 $-0.04B $0.13B -32.43%
2024-03-31 $-0.04B $0.12B -42.38%
2023-12-31 $-0.04B $0.13B -42.31%
2023-06-30 $-0.04B $0.00B -98.01%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.115B $0.090B
MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.919B 58.42
Doximity (DOCS) United States $11.317B 52.39
Hims & Hers Health (HIMS) United States $10.654B 110.70
Tempus AI (TEM) United States $10.042B 0.00
IRhythm Technologies (IRTC) United States $4.327B 0.00
Inspire Medical Systems (INSP) United States $3.691B 57.67
Hinge Health (HNGE) United States $3.687B 0.00
Privia Health (PRVA) United States $2.458B 168.00
Schrodinger (SDGR) United States $1.674B 0.00
Clover Health Investments (CLOV) United States $1.583B 0.00
Phreesia (PHR) United States $1.580B 0.00
Enovis (ENOV) United States $1.502B 8.38
Azenta (AZTA) United States $1.434B 66.64
10x Genomics (TXG) United States $1.421B 0.00
Omnicell (OMCL) United States $1.313B 23.17
Evolent Health (EVH) United States $1.146B 97.60
Claritev (CTEV) United States $0.705B 0.00
Fulgent Genetics (FLGT) United States $0.540B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Standard BioTools (LAB) United States $0.479B 0.00
Butterfly Network (BFLY) United States $0.465B 0.00
Talkspace (TALK) United States $0.427B 127.50
TruBridge (TBRG) United States $0.337B 746.67
Outset Medical (OM) United States $0.310B 0.00
Nyxoah SA (NYXH) Belgium $0.270B 0.00
Health Catalyst (HCAT) United States $0.269B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
CapsoVision (CV) United States $0.206B 0.00
Zepp Health (ZEPP) Netherlands $0.187B 0.00
KORU Medical Systems (KRMD) United States $0.160B 0.00
Pulmonx (LUNG) United States $0.128B 0.00
American Well (AMWL) United States $0.125B 0.00
EUDA Health Holdings (EUDA) Singapore $0.115B 0.00
CareCloud (CCLD) United States $0.100B 3.81
Insight Molecular Diagnostics (IMDX) United States $0.087B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.080B 0.00
111 (YI) China $0.066B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00